Map who decides, what depends on what, and where change propagates.

Institutions, programs, products, standards, payment pathways and evidence infrastructure are represented as connected decision objects—not isolated news items.

Accessible relationship table

From	Relationship	To	Type	Decision impact
CMS Innovation Center	operates	ACCESS Model	Explicit	Defines payment/adoption pathway
FDA CDRH	operates	TEMPO	Explicit	Defines TEMPO selection/evidence rules
TEMPO	includes	SonderMind / SACA	Explicit	SonderMind / SACA currently listed in TEMPO
TEMPO	includes	Limbic / Unpacked	Explicit	Limbic / Unpacked currently listed in TEMPO
TEMPO	includes	Cadence Solutions / HypertensionOS	Explicit	Cadence currently listed in TEMPO
TEMPO	includes	Dexcom Glucose Health Program	Explicit	Dexcom currently listed in TEMPO
ACCESS Model	creates payment context for	TEMPO	Explicit linkage	Regulation-payment convergence
ACCESS Model	provides a conditional designation pathway into	Medicare App Library	Explicit	CMS says pledged ACCESS participants are featured with a special ACCESS and coverage-status designation; this does not establish effectiveness or payment for other apps
CMS Aligned Networks	provides data connectivity to	Medicare App Library	Explicit	Enables patient-facing apps
ASTP/ONC	publishes current interoperability version	USCDI v7	Explicit	Current-version machine-readable health data context
HTI-5	could expand automated data access for	Conversational AI Assistants	Inferred from proposal	Could enable more agentic data access
FDA CDER	supports	FDA DHT Drug Development Program	Explicit	Builds DHT evidence methods
FDA CDER	supports	Real-Time Clinical-Trial POCs	Explicit	Accelerates trial evidence flow
ARPA-H	operates	PROSPR	Explicit	Federal healthspan R&D infrastructure
PROSPR	funds	THRIVE	Explicit	Healthspan score development
PROSPR	funds	VITAL-H	Explicit	Aging trial/regulatory path
PROSPR	funds	GPER agonist project	Explicit	Healthspan therapeutic test
ARPA-H	operates	ADVOCATE	Explicit	Prospective clinical-agentic-AI objective; solicitation closed
ARPA-H	operates	IGoR	Explicit	10× acceleration is a program target, not a result
NIA	convenes	Fifth Geroscience Summit	Explicit	May shape geroscience agenda
CY 2027 PFS	could change economics of	Remote Patient Monitoring	Explicit proposal	Changes RPM/RTM viability
Electronic Prior Authorization	depends on	USCDI v7	Inferred	Interoperability supports ePA
FDA AI-Enabled Medical Device List	provides regulatory landscape for	Conversational AI Assistants	Inferred	Separates regulated AI from general AI
Conversational AI Assistants	listed use case in	Medicare App Library	Explicit	Federal app-discovery path
Diabetes & Obesity Prevention/Management Apps	listed use case in	Medicare App Library	Explicit	Prevention-focused distribution path
P4L	monitors	ACCESS Model	P4L-declared relationship	Maintains payment/adoption intelligence
P4L	monitors	TEMPO	P4L-declared relationship	Maintains regulatory/RWE intelligence
P4L	monitors	PROSPR	P4L-declared relationship	Maintains healthspan-R&D intelligence
P4L	monitors	ADVOCATE	P4L-declared relationship	Maintains agentic-AI intelligence
P4L	monitors	Medicare App Library	P4L-declared relationship	Maintains digital-health distribution intelligence

This public intelligence capability distinguishes sourced facts from P4L interpretation and preserves evidence and provenance links. It is not medical advice.